IL6 and congestive heart failure: Across diverse geographic regions and clinical presentations—ranging from ambulatory chronic heart failure to acutely decompensated states—elevated baseline or persistent levels of IL-6, hs-CRP, and the neutrophil-to-lymphocyte ratio uniformly associate with increased risk of mortality, cardiovascular death, and recurrent heart failure hospitalizations.